https://careonco.ai/news/ Milestones and news from Care Onco Biotech, makers of TEPScan. en Sun, 01 Nov 2026 00:00:00 GMT https://careonco.ai/news/#cdsco-engagement-2026 https://careonco.ai/news/#cdsco-engagement-2026 Thu, 01 Jan 2026 00:00:00 GMT With the TEPScan kit formulated and 150 breast cancer validations complete, Care Onco has started regulatory work with India’s Central Drugs Standard Control Organisation (CDSCO), ahead of a Research Use Only launch for NSCLC and head & neck cancer. https://careonco.ai/news/#iiit-delhi-press-2026 https://careonco.ai/news/#iiit-delhi-press-2026 Mon, 05 Jan 2026 00:00:00 GMT The Tribune reported on the IIIT-Delhi research led by Prof. Debarka Sengupta that underpins TEPScan: an AI blood test that reads cancer-induced changes in platelets, including in Stage I and II disease. https://careonco.ai/news/#rashtriya-vigyan-puraskar-2025 https://careonco.ai/news/#rashtriya-vigyan-puraskar-2025 Wed, 01 Jan 2025 00:00:00 GMT Prof. Debarka Sengupta, inventor of TEPScan, received the Rashtriya Vigyan Puraskar (Vigyan Yuva–Shanti Swarup Bhatnagar) in Biological Sciences, one of India’s highest honours for science. https://careonco.ai/news/#bmc-genomics-2020 https://careonco.ai/news/#bmc-genomics-2020 Tue, 27 Oct 2020 00:00:00 GMT The peer-reviewed paper behind TEPScan showed that a signature of just 11 platelet genes enables accurate blood-based diagnosis of non-small cell lung cancer, matching the performance of a much larger gene panel.